Trevena Inc (TRVN.OQ)
23 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2013||Independent Chairman of the Board|
|59||President, Chief Executive Officer, Director|
|47||2013||Chief Financial Officer, Senior Vice President|
|55||2018||Chief Operating Officer, Executive Vice President|
|46||2014||Senior Vice President, General Counsel, Corporate Secretary|
- BRIEF-Trevena Inc Says FDA Indicated To Co That PDUFA Date For Olinvo NDA Is Nov 2
- BRIEF-Trevena Announces FDA Acceptance For Review Of New Drug Application For OLINVO(Oliceridine) Injection
- BRIEF-Trevena Inc says Q3 loss per share $0.27
- BRIEF-Trevena announces submission of NDA to U.S. FDA for Olinvo
- BRIEF-trevena announces publication and presentations of olinvo clinical data